{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:03:29Z","timestamp":1777439009625,"version":"3.51.4"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,21]]},"DOI":"10.7759\/cureus.76152","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T23:52:51Z","timestamp":1734825171000},"source":"Crossref","is-referenced-by-count":4,"title":["Autoimmune Polyglandular Syndrome Type 3: A Case Report"],"prefix":"10.7759","author":[{"given":"Joana","family":"Subtil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Filipa","family":"Rebelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Subtil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00602","article-title":"Autoimmune polyendocrinopathy","volume":"104","author":"Frommer L","year":"2019","unstructured":"Frommer L, Kahaly GJ. Autoimmune polyendocrinopathy. J Clin Endocrinol Metab. 2019, 104:4769-82. 10.1210\/jc.2019-00602","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12984","article-title":"Polyglandular autoimmune syndrome type III with a prevalence of cutaneous features","volume":"42","author":"Capo A","year":"2017","unstructured":"Capo A, Amerio P. Polyglandular autoimmune syndrome type III with a prevalence of cutaneous features. Clin Exp Dermatol. 2017, 42:61-3. 10.1111\/ced.12984","journal-title":"Clin Exp Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52372","article-title":"Autoimmune polyglandular syndrome II: a case report","volume":"16","author":"Awad O","year":"2024","unstructured":"Awad O, Basma H, Masri R, Hamadeh S, Hamadeh M. Autoimmune polyglandular syndrome II: a case report. Cureus. 2024, 16:e52372. 10.7759\/cureus.52372","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3109","article-title":"Clinical and genetic characteristics of autoimmune polyglandular syndrome type 3 variant in the Japanese population","volume":"97","author":"Horie I","year":"2012","unstructured":"Horie I, Kawasaki E, Ando T, et al.. Clinical and genetic characteristics of autoimmune polyglandular syndrome type 3 variant in the Japanese population. J Clin Endocrinol Metab. 2012, 97:E1043-50. 10.1210\/jc.2011-3109","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.06.083","article-title":"Human Leukocyte Antigen class II polymorphisms among Croatian patients with type 1 diabetes and autoimmune polyglandular syndrome type 3 variant","volume":"674","author":"Grubic Z","year":"2018","unstructured":"Grubic Z, Rojnic Putarek N, Maskalan M, et al.. Human Leukocyte Antigen class II polymorphisms among Croatian patients with type 1 diabetes and autoimmune polyglandular syndrome type 3 variant. Gene. 2018, 674:93-7. 10.1016\/j.gene.2018.06.083","journal-title":"Gene"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye ES","year":"2018","unstructured":"Husebye ES, Anderson MS, K\u00e4mpe O. Autoimmune polyendocrine syndromes. N Engl J Med. 2018, 378:1132-41. 10.1056\/NEJMra1713301","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01994-1","article-title":"Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy","volume":"46","author":"Betterle C","year":"2023","unstructured":"Betterle C, Furmaniak J, Sabbadin C, Scaroni C, Presotto F. Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy. J Endocrinol Invest. 2023, 46:643-65. 10.1007\/s40618-022-01994-1","journal-title":"J Endocrinol Invest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/328845-autoimmune-polyglandular-syndrome-type-3-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T23:52:52Z","timestamp":1734825172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/328845-autoimmune-polyglandular-syndrome-type-3-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.76152","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,21]]}}}